Objective: The cancer stem-like cells (CSC) CSC markers and the role derived from papillary thyroid carcinoma (PTC) in the pathogenesis is unclear. This study aims to determine the nature of CSC using a ball tumor cells passaged but without sorting PTC CSC.


Materials and Methods: To identify the properties of CSC derived from PTC, the expression of SRY-box transcription factor 2 (Sox2), octamer – bind transcription factor 4 (OCT 4 ), Nanog homeobox (NANOG), thyroglobulin (TG), thyroid-stimulating hormone receptor (TSHR), E-cadherin, YES-related protein 1 (YAP1), and signal transducer and activator transcription < / em> 3 (STAT3) was investigated in the field of serial tumor passaged without sorting CSC.


Results: Ball cultured tumor had cancer stemness; High expression of October 4 , Sox2, NANOG, and YAP1; Low expression of E-cadherin; and varied expression of TG, TSHR, and STAT3. PTC tumors ball transfected with small interfering RNA targeting YAP1 possess less of the ball CSC non-transfected tumors are doing.


Conclusions: Tumor sphere cells derived from PTC by passaging without sorting CSC has more stem cell-like properties, and less differentiation potential. Thus, a simple and cost-effective method can be used for enrichment PTC stemness to work in cell-based models, reducing the need for the use of animal models. Impact OCT4 and Its Related Signaling Pathways in Cancer Gastrointestinal: Focused on Targeted Therapies There are many pieces of evidence support the effects of cancer stem cells in the initiation and progression of cancer.

Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness
Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness

However, the related mechanisms involved in this phenomenon is much more complicated to understand. Stemness different functions factor in the cancer stem cells (CSC) and their complex associations at different levels of cancer have been reported. Therefore, it seems that the focus on a single master factor will be more helpful to solve the puzzle singling pathway in these cells. Octamer – bind transcription factor 4 (OCT 4 ) is also known as POU domain, class 5, transcription factor 1 (POU5F1), one of these pluripotency the factor , has an important role in both embryogenesis and tumorigenesis.

In this review, we collect information about the relationship of different markers to October 4 of expression in the three types of gastrointestinal cancers including esophageal, gastric and colorectal cancers. October 4 via different signaling pathways have an impact on different processes of gastrointestinal cancers such as proliferation, invasion, and metastasis. Based on the literature, Oct. 4 have a profound effect on the development of cancer at different stages, therefore we suggest it has potential implications in the choice of therapy.

Although the pharmacological action of cardiovascular Tanshinone IIA (TanIIA) have been extensively studied, research on the role in the regeneration of the heart is still sufficient. This study used H9c2 heart myoblast cell line to evaluate the possibility TanIIA role in cardiac regeneration. It was found that certain concentrations of TanIIA inhibited cell proliferation by suppressing the expression of proteins associated with cell cycle [cyclin dependent kinase (CDK) 4 , CDK6 and cyclin D1] and proliferation [c-Myc, octamer – bind transcription factor 4 (October 4 ) and growing multiply cell nuclear antigen (PCNA)] without inducing apoptosis.

EOSIN METHYLENE BLUE AGAR,LEVINE

E05-103-2kg 2kg
EUR 264

EOSIN METHYLENE BLUE AGAR,LEVINE

E05-103-500g 500 g
EUR 108

ETHYL VIOLET AZIDE BROTH

E05-105-10kg 10 kg
EUR 1302

ETHYL VIOLET AZIDE BROTH

E05-105-2kg 2kg
EUR 322

ETHYL VIOLET AZIDE BROTH

E05-105-500g 500 g
EUR 124

EUGONIC AGAR

E05-106-10kg 10 kg Ask for price

EUGONIC AGAR

E05-106-2Kg 2 Kg Ask for price

EUGONIC AGAR

E05-106-500g 500 g Ask for price

ENDO AGAR

E05-110-10kg 10 kg
EUR 2381

ENDO AGAR

E05-110-2Kg 2 Kg
EUR 557

ENDO AGAR

E05-110-500g 500 g
EUR 188

APT AGAR

A01-101-10kg 10 kg
EUR 1173

APT AGAR

A01-101-2Kg 2 Kg
EUR 294

APT AGAR

A01-101-500g 500 g
EUR 116

AGAR, BACTERIOLOGICAL

A01-102-10kg 10 kg
EUR 1684

AGAR, BACTERIOLOGICAL

A01-102-2kg 2kg
EUR 405

AGAR, BACTERIOLOGICAL

A01-102-500g 500 g
EUR 146

AGAR, HIGH GEL

A01-102IHG-10kg 10 kg
EUR 2219

AGAR, HIGH GEL

A01-102IHG-2Kg 2 Kg
EUR 521

AGAR, HIGH GEL

A01-102IHG-500g 500 g
EUR 178

AGAR,NOBLE

A01-102N-10kg 10 kg
EUR 3910

AGAR,NOBLE

A01-102N-2kg 2kg
EUR 889

AGAR,NOBLE

A01-102N-500g 500 g
EUR 278

ALT. THIOGLYCOLLATE MED.

A01-103-10kg 10 kg Ask for price

ALT. THIOGLYCOLLATE MED.

A01-103-2Kg 2 Kg Ask for price

ALT. THIOGLYCOLLATE MED.

A01-103-500g 500 g Ask for price

AMIES BROTH WITH CHARCOAL

A01-104-10kg 10 kg Ask for price

AMIES BROTH WITH CHARCOAL

A01-104-2kg 2kg Ask for price

AMIES BROTH WITH CHARCOAL

A01-104-500g 500 g Ask for price

AMIES BROTH W/O CHARCOAL

A01-105-10kg 10 kg Ask for price

AMIES BROTH W/O CHARCOAL

A01-105-2Kg 2 Kg Ask for price

AMIES BROTH W/O CHARCOAL

A01-105-500g 500 g Ask for price

AZIDE BLOOD AGAR BASE

A01-113-10kg 10 kg
EUR 2532

AZIDE BLOOD AGAR BASE

A01-113-2kg 2kg
EUR 589

AZIDE BLOOD AGAR BASE

A01-113-500g 500 g
EUR 197

AZIDE DEXTROSE BROTH

A01-114-10kg 10 kg
EUR 868

AZIDE DEXTROSE BROTH

A01-114-2Kg 2 Kg
EUR 228

AZIDE DEXTROSE BROTH

A01-114-500g 500 g
EUR 98

ANAEROBIC AGAR

A01-115-10kg 10 kg
EUR 2556

ANAEROBIC AGAR

A01-115-2kg 2kg
EUR 595

ANAEROBIC AGAR

A01-115-500g 500 g
EUR 198

A-1 MEDIUM

A01-116-10kg 10 kg
EUR 1034

A-1 MEDIUM

A01-116-2Kg 2 Kg
EUR 264

A-1 MEDIUM

A01-116-500g 500 g
EUR 108

AGAROSE 25G-125G -500G

A01-118-10kg 10 kg Ask for price

AGAROSE 25G-125G -500G

A01-118-2kg 2kg Ask for price

AGAROSE 25G-125G -500G

A01-118-500g 500 g
EUR 494

IL-2 Receptor ?, Human Recombinant

7100-10
EUR 196

IL-2 Receptor ?, Human Recombinant

7100-50
EUR 637

Human CellExp? IL-4 R?, Human Recombinant

7101-10
EUR 229

Human CellExp? IL-4 R?, Human Recombinant

7101-50
EUR 881

Human CellExp? IL-6 R?, Human Recombinant

7102-10
EUR 207

Human CellExp? IL-6 R?, Human Recombinant

7102-50
EUR 800

IL-9, Rat Recombinant

7103-10
EUR 278

IL-9, Rat Recombinant

7103-50
EUR 1132

IL-12p80, Human Recombinant

7104-10
EUR 392

IL-12p80, Human Recombinant

7104-50
EUR 1675

IL-17A, Mouse Recombinant

7105-10
EUR 196

IL-17A, Mouse Recombinant

7105-50
EUR 675

IL-17B, Human Recombinant

7106-10
EUR 196

IL-17B, Human Recombinant

7106-50
EUR 675

IL-17D, Human Recombinant

7107-10
EUR 196

IL-17D, Human Recombinant

7107-50
EUR 675

Human CellExp? IL-34, Human Recombinant

7108-10
EUR 278

Human CellExp? IL-34, Human Recombinant

7108-50
EUR 1132

IL-36RA, Human Recombinant

7109-10
EUR 196

IL-36RA, Human Recombinant

7109-50
EUR 675

IL-36?, Human Recombinant

7110-10
EUR 278

IL-36?, Human Recombinant

7110-50
EUR 1132

IL-36?, Human Recombinant

7111-10
EUR 278

IL-36?, Human Recombinant

7111-50
EUR 1132

Activin B, Human Recombinant

7112-10
EUR 479

Activin B, Human Recombinant

7112-50
EUR 2094

AITRL, Human Recombinant

7113-10
EUR 251

AITRL, Human Recombinant

7113-50
EUR 936

Amphiregulin, Human Recombinant

7114-10
EUR 147

Amphiregulin, Human Recombinant

7114-50
EUR 376

ANG-1, Human Recombinant

7115-10
EUR 251

ANG-1, Human Recombinant

7115-50
EUR 936

ANG-2, Human Recombinant

7116-10
EUR 251

ANG-2, Human Recombinant

7116-50
EUR 936

APRIL, Human Recombinant

7117-10
EUR 311

APRIL, Human Recombinant

7117-50
EUR 1300

APRIL, Mouse Recombinant

7118-10
EUR 196

APRIL, Mouse Recombinant

7118-50
EUR 675

Betacellulin, Murine Recombinant

7119-10
EUR 196

Betacellulin, Murine Recombinant

7119-50
EUR 675

Cardiotrophin-1, Murine Recombinant

7121-10
EUR 278

Cardiotrophin-1, Murine Recombinant

7121-50
EUR 1132

sCD100/Semaphorin-4D, Human Recombinant

7126-10
EUR 251

sCD100/Semaphorin-4D, Human Recombinant

7126-50
EUR 936

CTGFL/WISP-2, Human Recombinant

7129-10
EUR 234

CTGFL/WISP-2, Human Recombinant

7129-50
EUR 860

Human CellExp? DKK-1, Human Recombinant

7132-10
EUR 278

Human CellExp? DKK-1, Human Recombinant

7132-50
EUR 1132

Human CellExp? sDLL-1, Human Recombinant

7133-10
EUR 207

Human CellExp? sDLL-1, Human Recombinant

7133-50
EUR 675

Human CellExp? sDLL-4, Human Recombinant

7134-10
EUR 207

Human CellExp? sDLL-4, Human Recombinant

7134-50
EUR 675

Eotaxin-2/CCL24, murine recombinant

7137-10
EUR 207

Eotaxin-2/CCL24, murine recombinant

7137-50
EUR 675

Eotaxin-3/CCL26, human recombinant

7138-10
EUR 207

Eotaxin-3/CCL26, human recombinant

7138-50
EUR 675

Human CellExp? Fetuin A/ASHG, Human Recombinant

7142-10
EUR 153

Human CellExp? Fetuin A/ASHG, Human Recombinant

7142-50
EUR 381

Histone H3 Peptide, biotin conjugate

7143-01
EUR 240

Histone H3 Peptide, biotin conjugate

7143-1
EUR 1132

Histone H4 Peptide, tetra-acetylated, biotin conjugate

7144-01
EUR 240

Histone H4 Peptide, tetra-acetylated, biotin conjugate

7144-1
EUR 1132

FGF-5, human recombinant

7147-10
EUR 142

FGF-5, human recombinant

7147-50
EUR 359

FGF-6, human recombinant

7148-10
EUR 207

FGF-6, human recombinant

7148-50
EUR 675

FGF-16, human recombinant

7149-10
EUR 207

FGF-16, human recombinant

7149-50
EUR 675

FGF-17, human recombinant

7150-10
EUR 207

FGF-17, human recombinant

7150-50
EUR 675

FGF-23, human recombinant

7151-10
EUR 229

FGF-23, human recombinant

7151-50
EUR 860

GASP-1, human recombinant

7152-10
EUR 229

GASP-1, human recombinant

7152-50
EUR 833

GCP-2 (CXCL6), human recombinant

7153-10
EUR 207

GCP-2 (CXCL6), human recombinant

7153-50
EUR 675

BMP-9/GDF-2, human recombinant

7154-10
EUR 278

BMP-9/GDF-2, human recombinant

7154-50
EUR 1132

BMP-11/GDF-11, human recombinant

7155-10
EUR 240

BMP-11/GDF-11, human recombinant

7155-50
EUR 860

Gremlin-1, human recombinant

7159-10
EUR 142

Gremlin-1, human recombinant

7159-50
EUR 359

ICAM-1, human recombinant

7161-10
EUR 142

ICAM-1, human recombinant

7161-50
EUR 359

IFN-?1, human recombinant

7162-10
EUR 207

IFN-?1, human recombinant

7162-50
EUR 735

IFN-?2, human recombinant

7163-10
EUR 207

IFN-?2, human recombinant

7163-50
EUR 675

IGF-BP2, human recombinant

7165-10
EUR 251

IGF-BP2, human recombinant

7165-50
EUR 936

IGF-BP4, human recombinant

7166-10
EUR 251

IGF-BP4, human recombinant

7166-50
EUR 936

IGF-BP7, human recombinant

7167-10
EUR 207

IGF-BP7, human recombinant

7167-50
EUR 675

MCP-5/CCL12, murine recombinant

7168-10
EUR 207

MCP-5/CCL12, murine recombinant

7168-50
EUR 675

MIP-1?/CCL3, human recombinant

7173-10
EUR 207

MIP-1?/CCL3, human recombinant

7173-50
EUR 675

MIP-1?/CCL9/10, murine recombinant

7174-10
EUR 207

MIP-1?/CCL9/10, murine recombinant

7174-50
EUR 675

MIP-3/CCL23, human recombinant

7175-10
EUR 207

MIP-3/CCL23, human recombinant

7175-50
EUR 675

Nesfatin-1, human recombinant

7178-10
EUR 137

Nesfatin-1, human recombinant

7178-50
EUR 272

Human CellExp? PECAM-1, Human Recombinant

7184-10
EUR 153

Human CellExp? PECAM-1, Human Recombinant

7184-50
EUR 381

PF-4/CXCL4, murine recombinant

7187-10
EUR 207

PF-4/CXCL4, murine recombinant

7187-50
EUR 675

R-Spondin-1, human recombinant

7189-10
EUR 207

R-Spondin-1, human recombinant

7189-50
EUR 675

R-Spondin-2, human recombinant

7190-10
EUR 207

R-Spondin-2, human recombinant

7190-50
EUR 675

R-Spondin-3, human recombinant

7191-10
EUR 207

R-Spondin-3, human recombinant

7191-50
EUR 675

In this process, the expression of cardiac troponin in the treated cells was significantly increased and the migration of cells to the wound area to be treated is significantly improved.